Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma

British Journal of Haematology

Volumn 139, Issue 1, 2007, Pages 90-93

  Fabbri, Alberto ^a,b   Lenoci, Mariapia ^b   Gozzetti, Alessandro ^b   Chitarrelli, Ida ^b   Olcese, Francesca ^c   Raspadori, Donatella ^b   Gobbi, Marco ^b   Lauria, Francesco ^b  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Cyclophosphamide; Elderly; Indolent non Hoddgkin lymphoma; Low dose; Oral fludarabine

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG EFFICACY; ELDERLY CARE; FEMALE; HUMAN; INFECTION; LOW DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; OBSERVATIONAL STUDY; PNEUMONIA; PRIORITY JOURNAL; SOFT TISSUE INFECTION; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL RATE; VIDARABINE;

EID: 34548567362     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06746.x     Document Type: Article

References (15)

1. Bocchia, M., Bigazzi, C., Marconcini, S., Forconi, F., Marotta, G., Algeri, R. Lauria, F. (1999) Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment of low grade non Hodgkin lymphoma. Haematology, 84, 716 720.
2. Bollosillo, B., Villamour, N., Colomer, D., Pons, G., Montserrat, F. Gil, J. (1999) In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-Cell chronic lymphocytic leukaemia. Blood, 94, 2836 2843.
3. Boogaerts, M.A., Van Hoof, A., Catovsky, D., Kovacs, M., Montillo, M., Zinzani, P.L., Binet, J.L., Feremans, W., Marcus, R., Bosch, F., Verhoef, G. Klein, M. (2001) Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukaemia. Journal of Clinical Oncology, 19, 4252 4258.
4. Cheson, B.D., Horning, S.J., Coiffier, B., Shipp, M.A., Fisher, R.I., Connors, J.M., Lister, T.A., Vose, J., Grillo-Lopez, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N.L., Armitage, J.O., Carter, W., Hoppe, R. Cannellos, J.P. (1999) Report of an international workshop to standardize response criteria for non-Hodgkin lymphomas. NCI sponsored International Working Group. Journal of Clinical Oncology, 17, 1244 1253.
5. Chun, H.G., Leyland-Jones, B. Cheson, B.D. (1991) Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies. Journal of Clinical Oncology, 9, 175 188.
6. Fabbri, A., Lenoci, M., Gozzetti, A., Marotta, G., Raspadori, D., Forconi, F. Lauria, F. (2004) Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders. The Hematology Journal, 5, 472 474.
7. Frewin, R., Turner, D., Tighe, M., Davies, S. Johnson, S. (1999) Combination therapy with fludarabine and cyclophosphamide salvage treatment in lymphoproliferative disorders. British Journal of Haematology, 104, 612 613.
8. Kawai, Y. Plunkett, W. (1999) DNA repair induced by 4-hydroperoxy- cyclophosphamide permits fludarabine nucleotide incorporation and is associated with synergistic induction of apoptosis in quiescent human lymphocytes (abstract 2910). Blood, 94 (Suppl. 655a.
9. Marotta, G., Bigazzi, C., Lenoci, M., Tozzi, M., Bocchia, M. Lauria, F. (2000) Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leucemia refractory to conventional therapy. Haematologica, 85, 1268 1270.
10. O'Brien, S.M., Kantarjian, H.M., Cortes, J., Beran, M., Koeller, G.A., Giles Lerner, S. Keating, M. (2001) Results of fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukaemia. Journal of Clinical Oncology, 19, 1414 1420.
11. Plosker, G.L. Figgitt, D.P. (2003) Oral fludarabine. Drugs, 63, 2317 2323.
12. Shvidel, L., Shtarlid, M., Bairey, O., Rahimi-Levene, N., Lugassy, G., Shpilberg, O., Polliack, A., Berrebi, A., Israeli Study Group on CLL 2003) Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukaemia. Leukemia and Lymphoma, 44, 1947 1950.
13. Stefoni, V., Alinari, L., Musuraca, G., Tani, M., Marchi, E., Gabriele, A., Fina, M., Pileri, S., Baccarani, M. Zinzani, P.L. (2005) Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. Leukemia and Lymphoma, 46, 1839 1841.
14. Tam, C.S., Wolf, M.M., Januszewicz, E.H., Prince, H.M., Westerman, D. Seymour, J.F. (2004) Fludarabine and cyclophosphamide using an attenuated dose schedule is highly effective regimen for patients with indolent lymphoid malignancies. Cancer, 100, 2181 2189.
15. Tobinai, K., Watanabe, T., Ogura, M., Morishima, Y., Ogawa, Y., Ishizawa, K., Minami, H., Utsunomiya, A., Taniwaki, M., Terauchi, T., Nawano, S., Matsusako, M., Matsuno, Y., Nakamura, S., Mori, S., Ohashi, Y., Hayashi, M., Seriu, T. Hotta, T. (2006) Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non Hodgkin's lymphoma. Journal of Clinical Oncology, 24, 174 180.